Literature DB >> 2970386

Serological response in patients with chronic asymptomatic human immunodeficiency virus infection.

B O Lindhardt1, K Ulrich, P Kusk, B Hofmann.   

Abstract

To examine a possible relationship between decreased immune function and serological parameters, such as human immunodeficiency virus (HIV) antigenaemia and the quality and quantity of whole virus antibodies and antibodies against the major core protein p24, we investigated 160 healthy HIV infected individuals (CDC classification II and III). According to the number of T-helper lymphocytes (CD4 cells) these were divided into two groups (CD4 cell counts above or below 500/microliter), which according to the lymphocyte transformation response to pokeweed mitogen (response above or below 20% of control value) were further subdivided into two groups. Both the presence of HIV antigen (p = 0.022) and the absence of p24 antibodies (p = 0.001) correlated to a decreased CD4 cell count. Lack of p24 antibodies was more frequent than was the presence of HIV antigen among persons with decreased CD4 cell count and decreased response to pokeweed mitogen, indicating that absence of p24 antibodies may be an earlier marker of immune dysfunction than the presence of HIV antigen. In persons with p24 antibodies present, a low such titer was associated with a decrease of both immune parameters. Presence of HIV antigen and absence of p24 antibodies thus seems to correlate with the severity of immune dysfunction in healthy HIV infected individuals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970386     DOI: 10.1007/bf01962344

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  32 in total

1.  Human immunodeficiency viruses.

Authors:  J Coffin; A Haase; J A Levy; L Montagnier; S Oroszlan; N Teich; H Temin; K Toyoshima; H Varmus; P Vogt
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

2.  Serological characterization of HTLV-III infection in AIDS and related disorders.

Authors:  J E Groopman; F W Chen; J A Hope; J M Andrews; R L Swift; C V Benton; J L Sullivan; P A Volberding; D P Sites; S Landesman
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

3.  Antibodies to human T-cell lymphotropic virus type III in promiscuous healthy homosexual men. Relation to immunological and clinical findings.

Authors:  J Gerstoft; B O Lindhardt; C S Petersen; S Kroon; S Ullman; S Møller; J O Nielsen; E Dickmeiss
Journal:  Eur J Clin Invest       Date:  1985-10       Impact factor: 4.686

4.  Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion.

Authors:  A E Wittek; M A Phelan; M A Wells; L K Vujcic; J S Epstein; H C Lane; G V Quinnan
Journal:  Ann Intern Med       Date:  1987-09       Impact factor: 25.391

5.  Diagnostic significance of quantitative determination of HIV antibody specific for envelope and core proteins.

Authors:  G G Frösner; V Erfle; W Mellert; R Hehlmann
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

6.  Immunological changes in lymphadenopathy virus positive and negative symptomless male homosexuals: two years of observation.

Authors:  K Schwartz; B R Visscher; R Detels; J Taylor; P Nishanian; J L Fahey
Journal:  Lancet       Date:  1985-10-12       Impact factor: 79.321

7.  Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia.

Authors:  F de Wolf; J Goudsmit; D A Paul; J M Lange; C Hooijkaas; P Schellekens; R A Coutinho; J van der Noordaa
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-05

8.  Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection.

Authors:  Y Z Cao; F Valentine; S Hojvat; J P Allain; P Rubinstein; M Mirabile; S Czelusniak; M Leuther; L Baker; A E Friedman-Kien
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

9.  Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease.

Authors:  S Zolla-Pazner; D C Des Jarlais; S R Friedman; T J Spira; M Marmor; R Holzman; D Mildvan; S Yancovitz; U Mathur-Wagh; J Garber
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

10.  Antibody to human lymphotropic virus type III: immunologic status of homosexual contacts of patients with the acquired immunodeficiency syndrome and the acquired immunodeficiency-related complex.

Authors:  J M Goldsmith; S B Kalish; D G Ostrow; J Britz; J S Chmiel; C B Wallemark; J P Phair
Journal:  Sex Transm Dis       Date:  1987 Jan-Mar       Impact factor: 2.830

View more
  2 in total

1.  Antibodies against the major core protein p24 of human immunodeficiency virus: relation to immunological, clinical and prognostic findings.

Authors:  B O Lindhardt; J Gerstoft; B Hofmann; G Pallesen; L Mathiesen; E Dickmeiss; K Ulrich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

2.  Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.

Authors:  T H Bugge; B O Lindhardt; L L Hansen; P Kusk; E Hulgaard; K Holmbäck; P J Klasse; J Zeuthen; K Ulrich
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.